Accredited learning modules
RACGP-accredited activities
40 POINTS
T2D management and treatment selection in complex patients, including those with established cardiovascular disease (CVD) and/or chronic kidney disease (CKD), in light of CV outcome trials. Start Learning
40 POINTS
Metabolic syndrome diagnosis and management of associated risk factors.
2 POINTS
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling. Start Learning
2 POINTS
Best practise management of patients with pancreatic exocrine insufficiency (PEI).
RACP Category 1
This activity will focus on the management of existing patients diagnosed with RA who are showing incomplete response to conventional disease-modifying antirheumatic drugs (cDMARD) Start Learning
A case study-based activity focusing on patient selection for, and practical aspects of, tyrosine kinase inhibitors in RAI-R DTC. Start Learning
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling. Start Learning
PSA CPD Credits
2 CREDITS
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on dispensing and counselling. Start Learning
Past events
Your patients, your government
MULTIDISCIPLINARY FORUM AND WORKSHOP, PARLIAMENT HOUSE, SYDNEY. CLOSED EVENT
Panellists
Clinical Audits
Closed Courses
Ready to take your learning experience to the next level?
GET STARTED
